CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Petros Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Petros Pharmaceuticals Inc
1185 Avenue Of The Americas
3Rd Floor, Suite 570
Phone: (973) 242-0005p:973 242-0005 NEW YORK, NY  10036  United States Ticker: PTPIPTPI
Business Summary
Petros Pharmaceuticals, Inc. is focused on the self-care market by providing expanded access to key prescription pharmaceuticals such as OTC treatment options. The Company is engaged in developing a software-as-a-service (SaaS) platform designed to assist pharmaceutical companies in meeting FDA standards to assist in the Rx-to-OTC switch. In addition to the SaaS component, the platform is intended to incorporate software as a medical device (SaMD) capabilities, transforming traditional OTC medications into digitally enabled solutions. The SaMD interface seeks to be designed as customized and branded to pharmaceutical therapy and established as a specific application pathway to that therapy. Together, it aims to develop the SaaS and SaMD components to create a scalable, licensable platform that supports various classes of medications across the pharmaceutical industry, assisting pharmaceutical companies achieve regulatory approval, while delivering consumer-focused healthcare solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes---

Industries
SIC Code Description
7372 Prepackaged software
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Joshua N.Silverman 54 10/1/2024 1/1/2020
President, Chief Commercial Officer FadyBoctor 47 1/1/2020 1/1/2020
Chief Accounting Officer, Vice President - Finance MitchellArnold 61 1/1/2021 1/1/2021
Independent Director Bruce T.Bernstein 60 1/1/2020 1/1/2020
Independent Director Wayne R.Walker 65 1/1/2020 1/1/2020

Business Names
Business Name
Metuchen Pharmaceuticals LLC
Neurotrope, Inc.
Pos-T-Vac, LLC
PTPI
Timm Medical Technologies, Inc.

General Information
Number of Employees: 18 (As of 12/31/2024)
Outstanding Shares: 2,140,520 (As of 5/1/2025)
Shareholders: 312
Stock Exchange: NASD
Federal Tax Id: 851410058
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, May 12, 2025